Most sold healthcare stocks in Q3 2023

See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2023, measured as net reductions in reported share positions from Q2 2023 into Q3 2023. Notable reductions at the top of this list include CODEXIS INC (CDXS), INCYTE CORP (INCY), GE HEALTHCARE TECHNOLOGY (GEHC), GILEAD SCIENCES INC (GILD). These rankings aggregate SEC 13F filings from all institutional investors in our database.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
CDXSCODEXIS INC-4,885,641-$11.55M00111
INCYINCYTE CORP-2,870,618-$252.64M02315
GEHCGE HEALTHCARE TECHNOLOGY-2,503,455-$468.19M146114
GILDGILEAD SCIENCES INC-2,194,731-$168.55M067213
SNYSANOFI-ADR-1,869,986-$121.40M03317
PFEPFIZER INC-1,832,669-$82.11M1612021
SENSSENSEONICS HOLDINGS INC-1,779,445-$1.36K00010
MRKMERCK & CO. INC.-1,724,183-$187.42M3610123
MRNAMODERNA INC-1,707,414-$205.88M144211
HLNHALEON PLC-ADR-1,619,308-$15.91M02609
GHGUARDANT HEALTH INC-1,589,432-$60.50M01112
OCGNOCUGEN INC-1,550,005-$97400101
JNJJOHNSON & JOHNSON-1,522,402-$132.03M1913228
RHHBYROCHE HOLDINGS LTD-SPONS ADR-1,437,613-$54.92M00010
AGLAGILON HEALTH INC-1,403,786-$1.42M01203
ABTABBOTT LABORATORIES-1,401,208-$242.21M0310019
BDXBECTON DICKINSON AND CO-1,354,968-$380.80M049114
VTRSVIATRIS INC-1,300,926-$1.88M02317
IOVAIOVANCE BIOTHERAPEUTICS INC-1,251,478-$5.36M01112
CMRXCHIMERIX INC-1,030,200-$1.51K00101
TMOTHERMO FISHER SCIENTIFIC INC-920,073-$440.33M288221
BBIOBRIDGEBIO PHARMA INC-915,854$204.57M10102
AUPHAURINIA PHARMACEUTICALS INC-879,331-$1.07M01203
ABCLABCELLERA BIOLOGICS INC-844,550-$8.60K00101
ACHCACADIA HEALTHCARE CO INC-825,758-$102.23M02103
HRTXHERON THERAPEUTICS INC-767,800-$92900101
MASIMASIMO CORP-765,054-$122.26M01122
VXRTVAXART INC-757,305-$36000102
FMSFRESENIUS MEDICAL CARE-ADR-709,084-$58.21M10113
SGMOSANGAMO THERAPEUTICS INC-701,742-$2.57K00101
CERSCERUS CORP-700,285-$18.32M00202
SDGRSCHRODINGER INC-685,805-$246.54M01113
JYNTJOINT CORP/THE-681,049-$12.14M01011
ARDXARDELYX INC-661,720-$1.43K00101
HCAHCA HEALTHCARE INC-630,746-$461.88M12217
NKTRNEKTAR THERAPEUTICS-585,000$36500102
OGNORGANON & CO-567,328-$19.26M01608
FATEFATE THERAPEUTICS INC-563,099-$4.55K00202
ELANELANCO ANIMAL HEALTH INC-553,570$94.24M01305
CNCCENTENE CORP-515,468$282.97K02406
CTLTCATALENT INC-513,249-$21.73M00303
BNTXBIONTECH SE-ADR-500,648-$6.02M10314
DHRDANAHER CORP-496,190$41.53M339121
AMGNAMGEN INC-484,637-$29.07M139015
BKDBROOKDALE SENIOR LIVING INC-482,818-$418.52K00202
ADAPADAPTIMMUNE THERAPEUTICS-ADR-478,515-$3.24K00102
DCGODOCGO INC-425,966-$4.79M10021
ERASERASCA INC-409,600-$1.72K00101
NVAXNOVAVAX INC-394,670$302.42K01112
DVAXDYNAVAX TECHNOLOGIES CORP-341,703$1.39K00102
Net change in reported shares (all institutional filers) by symbol20 symbols with net change in reported shares from all institutional filers.−5.4M−4.0M−2.7M−1.3M0.00Net change in reported shares (all institutional filers)CDXSINCYGEHCGILDSNYPFESENSMRKMRNAHLNGHOCGNJNJRHHBYAGLABTBDXVTRSIOVACMRXSymbol

Frequently asked questions about Most sold healthcare stocks in Q3 2023

  • What are the most sold Healthcare stocks in Q3 2023?

    The most sold healthcare stocks in Q3 2023 are those with the largest decrease in reported share counts across institutional investors compared to Q2 2023, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2023?

    Among filers in this sector, net reductions were largest in companies such as CODEXIS INC (CDXS), INCYTE CORP (INCY), GE HEALTHCARE TECHNOLOGY (GEHC), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2023).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.